Overview

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the bioavailability of a single 1mg dose of treprostinil diethanolamine sustained release (SR) tablets manufactured by two independent facilities.
Phase:
Phase 1
Details
Lead Sponsor:
United Therapeutics
Treatments:
Treprostinil